Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: What can we learn from small studies?-Reference-Cited by-同舟云学术

Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: What can we learn from small studies?

Published:1997-05 Issue:5 Volume:21 Page:435-437
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Evans William E.,Relling Mary V.,Boyett James M.,Pui Ching-Hon

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference13 articles.

1. On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia;Seidel;Leukemia Research,1997

2. Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia;Evans;Lancet,1984

3. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia — identification of a relation between concentration and effect;Evans;New England Journal of Medicine,1986

4. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group study;Camitta;Journal of Clinical Oncology,1994

5. TX clearance is more important for intermediate-risk ALL (Letter);Evans;Journal of Clinical Oncology,1990

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study;British Journal of Haematology;2024-03-03

2. External evaluation and systematic review of population pharmacokinetic models for high-dose methotrexate in cancer patients;European Journal of Pharmaceutical Sciences;2023-07

3. Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia;Frontiers in Pharmacology;2021-07-13

4. Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients;BMC Cancer;2021-06-20

5. Association of GGH Promoter Methylation Levels with Methotrexate Concentrations in Chinese Children with Acute Lymphoblastic Leukemia;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2020-06-16